Dirk Arnold News Today

USA News Group Commentary VANCOUVER, BC, May 28, 2024 /PRNewswire/ -- USA News Group - Rates of cancer of the colorectal and anal regions have been on the rise for years in young adults

Investorideas.com, a global investor news source covering biotech and pharma stocks issues a sector snapshot on cancer immunotherapy featuring Oncolytics Biotech® Inc. , a clinical-stage...

Cancer Immunotherapy Stocks to Watch (NASDAQ: ONCY) (TSX: ONC) (Nasdaq: CADL) (Nasdaq: BNTX) (NASDAQ: IMTX)

Oncolytics Biotech Inc. announced the presentation of positive, interim results from the Phase 1/2 GOBLET study evaluating the combination of pelareorep and atezolizumab in second-line patients with...

/PRNewswire/ -- Phanes Therapeutics, Inc. (Phanes), a clinical stage biotech company focused on innovative drug discovery and development in oncology, today...

Distinguished, world renowned experts appointed to strengthen the development of Phanes three clinical programs in oncologySAN DIEGO, Sept. 5, 20...

Authorities say people who use the "business" are left with poor and often incomplete work — and often a sizeable invoice — before the scammers disappear into the wind.

/PRNewswire/ -- USA News Group - English actor, comedian and Monty Python alumnus Eric Idle credits early detection for his victory over pancreatic cancer,...

FN Media Group Presents USA News Group News Commentary VANCOUVER, British Colombia, Nov. 14, 2022 /PRNewswire/ -- USA News Group - English actor, comedian and Monty Python alumnus Eric

/PRNewswire/ -- Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC) today announced updated results from the phase 1/2 GOBLET studys first-line...